Tyler Seibert - new account

Really like your work Sam. Thank you. Transformative for those in studies with all their biases. As you know will be less in the real World. But I really like this figure. Will be interested in what experts in the field think @StephenVLiu @CharuAggarwalMD @MedwatchKate @DrSanjayPopat @FordePatrick @bensolomon1 @peters_solange @BalazsHalmosMD

Waiting for @TylerSbrt7 to unpack this in a 🧵 Thanks to the ProtecT trial team, the great pathologists who conducted the review, the OCHRe and CUH Tissue Bank teams who retrieved and digitised slides, and all trial participants @Freddie_Hamdy @Tristan_Radiol @ian263

After 28 years of visionary leadership, @soulehoward1 is retiring from PCF. His work has transformed treatments & impacted countless patients. We’re excited to welcome VP of Global Research & Innovation @AndreaMiyahira as we continue driving progress in prostate cancer research.

11 ▶️95% of EPE was pattern 3 extending beyond capsule ❌30% of SVI had crib+ cells in SV Implications: ⛔️Obsessing about EPE on MRI prob. not v helpful ✅We want to detect SVI, GG3, and cribriform‼️ @Adam_Weiner535 @LondonProstate1 @DoctorMargolis @Dr_RaviMadan

🚨The sequel is here!! The other 👞 drops. Cribriform morphology in ProtecT — now in prostatectomy specimens #ProstateCancer #radonc #UroSoMe @UroToday @APCCC_Lugano @PCF_Science @OncoAlert 🧵1️⃣

I could not have done it better! @TylerSbrt7 gets all the key messages across for the ProtecT surgical review 👇🏻 Next stop: looking at 20-year outcomes in more specimens AND doubling down on efforts to improve early detection of high-grade, T3b cribriform disease 🔬🩻